Catalog #CP111

RecombiMAb anti-mouse CD39 (Entpd1) (LALA-PG)

Clone C39Mab-1-CP111
Reactivities Mouse
Isotype Mouse IgG2a (LALA-PG), κ
(switched from Rat Ig2a, κ)

$560.00 - $7,581.50

$560.00 - $7.00

Choose an Option...
  • 25 mg - $7,581.50
  • 5 mg - $2,170.50
  • 1 mg - $560.00
  • Custom Amount (Quotes Only)
In stock
Only %1 left
You may also be interested in:

Product Description

The C39Mab-1-CP111 monoclonal antibody is a recombinant, chimeric version of the original C39Mab-1 antibody. The variable domain sequences are identical but the constant region sequences have been switched from Rat IgG2a, κ to mouse IgG2a, κ for use in murine models. Additionally, C39Mab-1-CP111 contains LALA-PG mutations in the heavy chain Fc fragment rendering it unable to bind endogenous murine Fcγ receptors or C1q to induce antibody-dependent, cell-mediated cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC). The LALA-PG variant has demonstrated significantly reduced effector function, C1q binding and C3 fixation compared to other common silencing mutations such as the LALA and DANG variants while retaining favorable biophysical and manufacturing properties. Species-matched chimeric antibodies demonstrate reduced immunogenicity and formation of anti-drug antibodies (ADAs) compared to xenogenic antibodies in animal models. The highly controlled sequence and lack of genetic drift in recombinant antibodies provide more reliable and reproducible results over hybridoma derived antibodies.

The C39Mab-1 monoclonal antibody reacts with mouse CD39, also known as ectonucleoside triphosphate diphosphohydrolase 1 (Entpd1), NTPDase-1, ATP-DPH, and Ecto-ATPase 1. The major function of CD39 is to hydrolyze extracellular adenosine triphosphate (eATP) to diphosphate (eADP) and adenosine monophosphate (AMP). 5’-nucleotidase (NT5E/CD73) dephosphorylates AMP to generate adenosine, which mediates an immunosuppressive tumor microenvironment in tumors. CD39 acts as an "immunological switch" by regulating the balance between immunostimulatory or pro-inflammatory eATP and immunosuppressive adenosine nucleotides, thereby controlling inflammation and immune responses. This function is critical in various processes, including immune cell regulation, anti-tumor immunity, and vascular inflammation.

Specifications

Isotype Mouse IgG2a (LALA-PG), κ
Recommended Isotype Control(s) RecombiMAb mouse IgG2a (LALA-PG) isotype control, anti-hen egg lysozyme
Recommended Dilution Buffer InVivoPure pH 7.0 Dilution Buffer
Mutations LALA-PG
Immunogen LN229 cells over-expressing mouse CD39
Reported Applications Flow cytometry
Western blot
For details on in vivo applications please contact technicalservice@bioxcell.com
Formulation PBS, pH 7.0
Contains no stabilizers or preservatives
Endotoxin ≤0.5EU/mg (≤0.0005EU/μg)
Determined by LAL assay
Aggregation <5%
Determined by SEC
Purity ≥95%
Determined by SDS-PAGE
Sterility 0.2 µm filtration
Production Purified from mammalian cell supernatant in an animal-free facility
Purification Protein A
Molecular Weight 150 kDa
Murine Pathogen Tests Ectromelia/Mousepox Virus: Negative
Hantavirus: Negative
K Virus: Negative
Lactate Dehydrogenase-Elevating Virus: Negative
Lymphocytic Choriomeningitis virus: Negative
Mouse Adenovirus: Negative
Mouse Cytomegalovirus: Negative
Mouse Hepatitis Virus: Negative
Mouse Minute Virus: Negative
Mouse Norovirus: Negative
Mouse Parvovirus: Negative
Mouse Rotavirus: Negative
Mycoplasma Pulmonis: Negative
Pneumonia Virus of Mice: Negative
Polyoma Virus: Negative
Reovirus Screen: Negative
Sendai Virus: Negative
Theiler’s Murine Encephalomyelitis: Negative
Storage The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
Need a Custom Formulation? See All Antibody Customization Options

Product FAQs

Additional Formats

  1. Catalog #BE0479
    InVivoMAb anti-mouse CD39 (Entpd1) Read more